Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Erin St. Onge"'
Autor:
Stacy Miller, Erin St. Onge, Shauna Buring, John Allen, Priti Patel, Joshua Pullo, Janet Schmittgen, Karen Whalen
Publikováno v:
Currents in Pharmacy Teaching and Learning. 15:101-109
Publikováno v:
Journal of Pharmacy Technology. 38:297-303
Objective: To review the safety, efficacy, and tolerability of daridorexant in treating insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients. Data Sources: A literature search was performed through PubMed
Publikováno v:
Annals of Pharmacotherapy. 55:1159-1166
Objective To describe the safety and efficacy of opicapone, a newly Food and Drug Administration–approved catechol- O-methyltransferase (COMT) inhibitor, as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) e
Autor:
W Cary Mobley, Erin St Onge
Publikováno v:
Annals of Pharmacotherapy. 55:105-110
Objective: To review the safety and efficacy of minocycline 4% topical foam for the treatment of moderate to severe acne vulgaris in adults and pediatric patients aged 9 years and older. Data Sources: A literature search through PubMed and EMBASE was
Autor:
Erin St. Onge, Bradley Phillips
Publikováno v:
Journal of Pharmacy Technology. :875512252311665
Objective: To review the safety, efficacy, and tolerability of vonoprazan for the treatment of Helicobacter pylori infection in adults. Data Sources: A literature search was performed through PubMed using the following key terms: vonoprazan, Voquezna
Publikováno v:
FP essentials. 504
Type 1 diabetes is defined as a state of hyperglycemia due to insulin deficiency caused by autoimmune pancreatic beta-cell destruction. The risk among individuals in the general population has been estimated at 0.5%. A family history of diabetes and
Autor:
Erin, St Onge
Publikováno v:
FP essentials. 504
For most patients with type 2 diabetes, the American Diabetes Association (ADA) recommends an A1c goal of less than 7%. However, this goal may be adjusted depending on certain patient factors. Metformin should be used as a first-line treatment in all
Publikováno v:
J Pharm Technol
Objective: To review the safety and efficacy of romosozumab (Evenity) in the treatment of osteoporosis in women. Data Sources: An English-language search of PubMed and Medline (1966 to August 2020) was conducted using the keywords romosozumab, sclero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::711ee28cc15e9f6732e8e5cd16e0fcf7
https://europepmc.org/articles/PMC7809324/
https://europepmc.org/articles/PMC7809324/
Autor:
Erin St Onge, Madeleine Morin
Publikováno v:
Food and Nutrition Sciences. 10:713-718
Studies have shown Hispanic patients are at an increasing risk of developing type 2 diabetes; however, little is known about whether gender plays a role. Several studies were examined to help answer this question. Results of studies found female Hisp
Publikováno v:
Food and Nutrition Sciences. :227-235
Obesity is a significant concern in the United States, affecting approximately 35% of the population. Comorbidities, such as diabetes, hypertension, and hyperlipidemia, significantly increase one’s risk of heart attack, stroke, and even death. Lira